DermWire TV

Episodes 1-16 of 121

FDA Approves Bimzelx for Hidradenitis Suppurativa
FDA Approves Bimzelx for Hidradenitis Suppurativa
DermWire TV
FDA Approves Bimzelx for Hidradenitis Suppurativa
DermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
DermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
Skin of Color
DermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
- Emily Ruiz, MD, MPH
FDA Approves Rosacea Treatment Emrosi
FDA Approves Rosacea Treatment Emrosi
DermWire TV
FDA Approves Rosacea Treatment Emrosi
DermWire TV Extra: Dr. Swanson on BPO
DermWire TV Extra: Dr. Swanson on BPO
DermWire TV
DermWire TV Extra: Dr. Swanson on BPO
- Lisa Swanson, MD, FAAD
DermWire TV Extra: Dr. Bunick on BPO Study
DermWire TV Extra: Dr. Bunick on BPO Study
DermWire TV
DermWire TV Extra: Dr. Bunick on BPO Study
- Christopher Bunick, MD, PhD, FAAD
FDA Approves Botox for Vertical Platysma Bands
FDA Approves Botox for Vertical Platysma Bands
DermWire TV
FDA Approves Botox for Vertical Platysma Bands
New Analysis of Benzene Contamination in BPO Products
New Analysis of Benzene Contamination in BPO Products
DermWire TV
New Analysis of Benzene Contamination in BPO Products
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
DermWire TV
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
- Melinda Gooderham, MSc, MD, FRCPC
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
DermWire TV
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
NIH Analysis Examines Association Between AD and Comorbidities
NIH Analysis Examines Association Between AD and Comorbidities
DermWire TV
NIH Analysis Examines Association Between AD and Comorbidities
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
DermWire TV
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
DermWire TV
DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
- Amber Blair, PA-C
FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
DermWire TV
FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
DermWire TV Extra: How ILDS Helps Dermatology Go Global
DermWire TV Extra: How ILDS Helps Dermatology Go Global
DermWire TV
DermWire TV Extra: How ILDS Helps Dermatology Go Global
- Neal Bhatia, MD
- Henry Lim, MD
Dermatology and CTCL: Recommendations
Dermatology and CTCL: Recommendations
DermWire TV
Dermatology and CTCL: Recommendations
- Larisa J. Geskin, MD
New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
DermWire TV
New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam

Prev
1
2
3
…
7
8
Next

1/6